Redx Pharma PLC (LSE:REDX)
£ 0.15 0.036 (31.58%) Market Cap: 58.35 Mil Enterprise Value: 57.94 Mil PE Ratio: 0 PB Ratio: 15.00 GF Score: 24/100

Redx Pharma PLC at Jefferies London Healthcare Conference Transcript

Nov 17, 2022 / 03:15PM GMT
Release Date Price: £0.58
Suji Jeong
Jefferies LLC - Analyst

Good afternoon, everyone. My name is Suji Jeong. And I'm one of the biotech research analysts at Jefferies. I'm excited to introduce our next presenting company, Redx Pharma. And joining us here today are Lisa Anson, the CEO of Redx; and also Peter Collum, the CFO. So now I'll turn it over to Lisa and Peter for the presentation.

Lisa Anson
Redx Pharma PLC - CEO

Great. Thanks. Thanks, Suji, and it's great to be here at Jefferies presenting the Redx story, which has moved forward fantastically in the last year, a lot of exciting progress. So I'm going to walk through that with you today with Pete. So obviously, we'll be making forward-looking statements in this presentation and usual disclaimers apply.

Just to round out our management team. I'm here so as our CEO; Pete, our CFO, pick up in a minute as we said. Key members of our leadership team, Richard Armer; and Jane Robertson, our CMO, are both long-standing and critical members of the Redx leadership team.

Redx, for those of you who don't know, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot